CD8 T-cell heterogeneity during T-cell exhaustion and PD-1-targeted immunotherapy

被引:11
|
作者
Ando, Satomi [1 ,2 ]
Araki, Koichi [1 ,2 ]
机构
[1] Cincinnati Childrens Hosp Med Ctr, Ctr Inflammat & Tolerance, Div Infect Dis, Cincinnati, OH 45229 USA
[2] Univ Cincinnati, Dept Pediat, Coll Med, Cincinnati, OH 45229 USA
基金
美国国家卫生研究院;
关键词
cancer; chronic infection; immune checkpoint inhibitors; T-cell exhaustion; T-cell heterogeneity; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; CHRONIC INFECTION; VIRAL VARIANTS; HEPATITIS-C; PD-1; PERSISTENCE; SUBSETS; HELP; SUPPRESSION; INTERFERON;
D O I
10.1093/intimm/dxac038
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Persistent antigenic stimulation results in loss of effector function or physical deletion of antigen-specific CD8 T cells. This T-cell state is called T-cell exhaustion and occurs during chronic infection and cancer. Antigen-specific CD8 T cells during T-cell exhaustion express the inhibitory receptor PD-1, the expression of which plays a major role in T-cell dysfunction. PD-1 blockade re-invigorates CD8 T-cell immunity and has been proven effective against many different types of human cancer. To further improve the efficacy of PD-1-targeted immunotherapy in cancer patients, a better understanding of T-cell exhaustion is required. Recent studies have revealed that antigen-specific CD8 T cells during T-cell exhaustion are heterogeneous and have also uncovered the detailed mechanisms for PD-1-targeted immunotherapy. Here, we review the CD8 T-cell subsets that arise during T-cell exhaustion, the lineage relationship among these individual subsets and the role of each subset in PD-1 blockade. Also, we discuss potential strategies to enhance the efficacy of PD-1-targeted immunotherapy.
引用
收藏
页码:571 / 577
页数:7
相关论文
共 50 条
  • [41] T-cell intrinsic and extrinsic mechanisms of p27KiP1 in the regulation of CD8 T-cell memory
    Jatzek, Anna
    Tejera, Melba Marie
    Plisch, Erin H.
    Fero, Matthew L.
    Suresh, M.
    IMMUNOLOGY AND CELL BIOLOGY, 2013, 91 (02): : 120 - 129
  • [42] Tissue-Specific Differences in PD-1 and PD-L1 Expression during Chronic Viral Infection: Implications for CD8 T-Cell Exhaustion
    Blackburn, Shawn D.
    Crawford, Alison
    Shin, Haina
    Polley, Antonio
    Freeman, Gordon J.
    Wherry, E. John
    JOURNAL OF VIROLOGY, 2010, 84 (04) : 2078 - 2089
  • [43] CD8 T-CELL CLONES INHIBIT ANTITUMOR T-CELL FUNCTION BY SECRETING IL-10
    ROHRER, JW
    COGGIN, JH
    JOURNAL OF IMMUNOLOGY, 1995, 155 (12): : 5719 - 5727
  • [44] Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1
    Marine Leclerc
    Elodie Voilin
    Gwendoline Gros
    Stéphanie Corgnac
    Vincent de Montpréville
    Pierre Validire
    Georges Bismuth
    Fathia Mami-Chouaib
    Nature Communications, 10
  • [45] PD-1 and BTLA and CD8+ T-cell "exhaustion" in cancer "Exercising" an alternative viewpoint
    Haymaker, Cara
    Wu, Richard
    Bernatchez, Chantale
    Radvanyi, Laszlo
    ONCOIMMUNOLOGY, 2012, 1 (05) : 735 - 738
  • [46] CD8 T-cell ability to exert immunodomination correlates with T-cell receptor: Epitope association rate
    Roy-Proulx, G
    Baron, C
    Perreault, C
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (04) : 260 - 271
  • [47] THE PERIPHERAL T-CELL REPERTOIRE - INDEPENDENT HOMEOSTATIC REGULATION OF VIRGIN AND ACTIVATED CD8(+) T-CELL POOLS
    TANCHOT, C
    ROCHA, B
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (08) : 2127 - 2136
  • [48] Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1
    Leclerc, Marine
    Voilin, Elodie
    Gros, Gwendoline
    Corgnac, Stephanie
    de Montpreville, Vincent
    Validire, Pierre
    Bismuth, Georges
    Mami-Chouaib, Fathia
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [49] The CD8 T-cell response during tolerance induction in liver transplantation
    Wong, Yik Chun
    McCaughan, Geoffrey W.
    Bowen, David G.
    Bertolino, Patrick
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2016, 5
  • [50] Immunotherapy for T-Cell ALL and T-Cell NHL
    DiPersio, John F.
    Staser, Karl
    Cooper, Matthew
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S56 - S58